APA (7th ed.) Citation

Jaramillo Segura, S., Scherer, M., Szu-Tu, C., Beneyto-Calabuig, S., Müller-Tidow, C., Schlenk, R. F., . . . Pabst, C. (2024). Late-onset NPM1 mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib. Haematologica, 109(11), . https://doi.org/10.3324/haematol.2023.284922

Chicago Style (17th ed.) Citation

Jaramillo Segura, Sonia, Michael Scherer, Chelsea Szu-Tu, Sergi Beneyto-Calabuig, Carsten Müller-Tidow, Richard Friedrich Schlenk, Michael Hundemer, Lars Velten, and Caroline Pabst. "Late-onset NPM1 Mutation in a MYC-amplified Relapsed/refractory Acute Myeloid Leukemia Patient Treated with Gemtuzumab Ozogamicin and Glasdegib." Haematologica 109, no. 11 (2024). https://doi.org/10.3324/haematol.2023.284922.

MLA (9th ed.) Citation

Jaramillo Segura, Sonia, et al. "Late-onset NPM1 Mutation in a MYC-amplified Relapsed/refractory Acute Myeloid Leukemia Patient Treated with Gemtuzumab Ozogamicin and Glasdegib." Haematologica, vol. 109, no. 11, 2024, https://doi.org/10.3324/haematol.2023.284922.